Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody

被引：0
|
作者：
Buhmann, R. [1 ]
Stanglmaier, M. [2 ]
Simoes, B. [3 ]
Menzel, H. [4 ]
Peschel, C. [4 ]
Ruf, P. [2 ]
Lindhofer, H. [2 ]
Kolb, H. -J. [3 ]
机构：
[1] LMU, Klinikum Grosshadern, Munich, Germany
[2] TRION Res, Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] TU, Klinikum Rechts Isar, Munich, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [21] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04) : A59 - A59
  • [22] Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
    Buhmann, Raymund
    Michael, Stanglmaier
    Juergen, Hess
    Horst, Lindhofer
    Peschel, Christian
    Kolb, Hans-Jochem
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [23] b Relapsed and refractory malignant B cell diseases: Evidence for therapeutic efficacy via subcutaneous administration of anti-CD20 x anti-CD3 antibody lymphomun
    Buhmann, R.
    Ruf, P.
    Hess, J.
    Lindhofer, H.
    Jacob, U.
    Dreyling, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S505 - S505
  • [24] Anti-CD3 antibody - MacroGenics Inc
    Brown, WM
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (04) : 381 - 388
  • [25] Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer
    Kiewe, Philipp
    Hasmueller, Stephan
    Kahlert, Steffen
    Heinrigs, Maja
    Rack, Brigitte
    Marme, Alexander
    Korfel, Agnieszka
    Jaeger, Michael
    Lindhofer, Horst
    Sommer, Harald
    Thiel, Eckhard
    Untch, Michael
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3085 - 3091
  • [26] Anti-CD20 monoclonal antibody in autoimmune diseases
    Pogliani, EM
    Larocca, A
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (07) : 350 - 351
  • [27] Ofatumumab, a human anti-CD20 monoclonal antibody
    Osterborg, Anders
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 439 - 449
  • [28] Anti-CD20 antibody wows in multiple sclerosis
    Cormac Sheridan
    Nature Biotechnology, 2015, 33 : 1215 - 1216
  • [29] T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro
    Gall, JM
    Davol, PA
    Grabert, RC
    Deaver, M
    Lum, LG
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (04) : 452 - 459
  • [30] Anti-CD20 antibody wows in multiple sclerosis
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1215 - 1216
12345